熱門資訊> 正文
Trinity Capital承诺向Neuros Medical提供3500万美元的增长资本
2026-03-10 21:24
- Trinity Capital (TRIN) on Tuesday said it has committed $35 million in growth capital to Neuros Medical.
- The financing will support the expansion and commercialization of Neuros Medical’s Altius Direct Electrical Nerve Stimulation System, which is designed to treat chronic post-amputation pain.
- Neuros Medical said the funding will also help scale adoption of the therapy and support expansion into new markets.
- TRIN +1.41% premarket to $15.07.
- Source: Press Release
More on Trinity Capital
- Trinity Capital: Strong Investment Setup (Rating Upgrade)
- Trinity Capital: Not Your Typical 13%+ Yielding BDC
- Trinity Capital: NAV Growth Continues In Q4
- Trinity Capital outlines $1.2B in unfunded commitments and monthly dividend transition amid robust portfolio growth
- Trinity Capital posts preliminary Q4, full-year 2025 results
推薦文章
港股見底了嗎？北水大舉加倉逾600億港元！大行看好4月做多窗口來臨，十大金股一圖睇全
華盛早報 | 伊朗與阿曼擬共管霍爾木茲！美股V型反轉；伊朗襲擊甲骨文、亞馬遜數據中心；港美股今日因假期休市一天
諾和諾德稱：口服版Wegovy減肥效果優於禮來GLP‑1口服藥
美股機會日報 | 特朗普粉碎停戰幻想！恐慌指數飆升12%，納指期貨跌約2%；美油期貨暴漲超9%！油氣股飆升，美國原油基金ETF漲超9%
清明休市提醒 | 港股本周五休市，下周三恢復交易；美股周五休市一天
油價上漲 此前特朗普表示伊朗衝突可能在未來幾周升級
野村：特朗普講話未能發出局勢降温的明確信號
市場樂觀預期伊朗戰爭將落幕，油價跌破100美元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
